Clinical evaluation of FAPlus/FNPlus bottles compared with the combination of SA/SN and FA/FN bottles in the BacT/Alert blood culture system.

BacT/Alert Blood culture Helicobacter cinaedi Time to positivity

Journal

The journal of medical investigation : JMI
ISSN: 1349-6867
Titre abrégé: J Med Invest
Pays: Japan
ID NLM: 9716841

Informations de publication

Date de publication:
2020
Historique:
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 16 6 2021
Statut: ppublish

Résumé

Background : The comparison of the performance of FAPlus/FNPlus bottles and combination of SA/SN and FA/FN bottles is not yet reported. Methods : We used human blood samples to investigate microorganism detection rates and the time to positivity (TTP) in a before-vs.-after study (a combination of SA/SN and FA/FN bottles from September 2012 to August 2013 vs. FAPlus/FNPlus bottles from September 2013 to August 2014). Results : The microorganism detection rate was significantly higher in the later period than in the earlier period (11.2% vs. 9.6%, P < 0.001), particularly for Enterococcus and Streptococcus species, nonfermentative Gram-negative bacilli, and Helicobacter cinaedi. TTP for pathogens was longer when FAPlus/FNPlus bottles were used than when a combination of SA/SN and FA/FN bottles was used (14.9 vs. 13.3 h, P = 0.014), particularly, in the case of Gram-negative bacilli including Escherichia coli. Conclusion : The microorganism detection rate was improved with the use of FAPlus/FNPlus bottles compared with the combination of SA/SN and FA/FN bottles ; however, FAPlus/FNPlus bottles seemed to be inferior to SA/SN and FA/FN bottles in terms of TTP. J. Med. Invest. 67 : 90-94, February, 2020.

Identifiants

pubmed: 32378625
doi: 10.2152/jmi.67.90
doi:

Types de publication

Comparative Study Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

90-94

Auteurs

Takuya Hattori (T)

Department of Clinical Laboratory, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

Hideki Nishiyama (H)

Department of Clinical Laboratory, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

Shinobu Ikegami (S)

Department of Clinical Laboratory, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

Makoto Minoshima (M)

Department of Clinical Laboratory, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

Hideki Kato (H)

Department of Clinical Laboratory, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

Norihiro Yuasa (N)

Department of Clinical Laboratory, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH